Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: S100A8 and S100A9 have been gaining recognition for modulating tumor growth and metastasis. This study aimed at evaluating the clinical significance of S100A8 and S100A9 in non-small cell lung cancer (NSCLC). Methods: We analyzed the relationship between S100A8 and S100A9 expressions, clinicopathological characteristics, and prognostic significance in tumor cells and peritumoral inflammatory cells. Results: The positive staining of S100A8 in tumor cells was significantly increased in male (p < .001), smoker (p = .034), surgical method other than lobectomy (p = .024), squamous cell carcinoma (SQCC) (p < .001) and higher TNM stage (p = .022) compared with female, non-smoker, lobectomy, adenocarcinoma (ADC), and lower stage. The proportion of tumor cells stained for S100A8 was related to histologic type (p < .001) and patient sex (p = .027). The proportion of inflammatory cells stained for S100A8 was correlated with patient age (p = .022), whereas the proportion of inflammatory cells stained for S100A9 was correlated with patient sex (p < .001) and smoking history (p = .031). Moreover, positive staining in tumor cells, more than 50% of the tumor cells stained and less than 30% of the inflammatory cells stained for S100A8 and S100A9 suggested a tendency towards increased survivability in SQCC but towards decreased survivability in ADC. Conclusions: S100A8 and S100A9 expressions might be potential prognostic markers in patients with NSCLC.
Abstract
Background: S100A8 and S100A9 have been gaining recognition for modulating tumor growth and metastasis. This study aimed at evaluating the clinical significance of S100A8 and S100A9 in non-small cell lung cancer (NSCLC). Methods: We analyzed the relationship between S100A8 and S100A9 expressions, clinicopathological characteristics, and prognostic significance in tumor cells and peritumoral inflammatory cells. Results: The positive staining of S100A8 in tumor cells was significantly increased in male (p < .001), smoker (p = .034), surgical method other than lobectomy (p = .024), squamous cell carcinoma (SQCC) (p < .001) and higher TNM stage (p = .022) compared with female, non-smoker, lobectomy, adenocarcinoma (ADC), and lower stage. The proportion of tumor cells stained for S100A8 was related to histologic type (p < .001) and patient sex (p = .027). The proportion of inflammatory cells stained for S100A8 was correlated with patient age (p = .022), whereas the proportion of inflammatory cells stained for S100A9 was correlated with patient sex (p < .001) and smoking history (p = .031). Moreover, positive staining in tumor cells, more than 50% of the tumor cells stained and less than 30% of the inflammatory cells stained for S100A8 and S100A9 suggested a tendency towards increased survivability in SQCC but towards decreased survivability in ADC. Conclusions: S100A8 and S100A9 expressions might be potential prognostic markers in patients with NSCLC.
참고문헌 (35)
- 조영민, "Prognostic Significance of Aquaporin 5 Expression in Non-small Cell Lung Cancer", Journal of Pathology and Translational Medicine, 50(2), pp.122~128 (2016), 대한병리학회[DOI]
- 이상화, "Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey", Journal of Pathology and Translational Medicine, 49(6), pp.481~488 (2015), 대한병리학회[DOI]
- Fan B, "Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer", BMC Cancer, 12, pp.316~ (2012)
- Yasar O, "Significance of S100A8, S100A9 and calprotectin levels in bladder cancer", Scand J Clin Lab Invest, 77, pp.437~441 (2017)
- Salama I, "A review of the S100proteins in cancer", Eur J Surg Oncol, 34, pp.357~364 (2008)
- Gebhardt C, "S100A8 and S100A9 in inflammation and cancer", Biochem Pharmacol, 72, pp.1622~1631 (2006)
- Lang B, "Targeted silencing of S100A8 gene by miR-24 to increase chemotherapy sensitivity of endometrial carci-noma cells to paclitaxel", Med Sci Monit, 22, pp.1953~1958 (2016)
- Srikrishna G., "S100A8 and S100A9 : new insights into their roles in malignancy", J Innate Immun, 4, pp.31~40 (2012)
- Hiratsuka S, "Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis", Nat Cell Biol, 8, pp.1369~1375 (2006)
- Lim SY, "Tumor-infiltrating monocytes", macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells, 2016, pp.35, 5735~5745
- Hiratsuka S, "The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase", Nat Cell Biol, 10, pp.1349~1355 (2008)
- Weidle UH, "The multiple roles of exosomes in metastasis", Cancer Genomics Proteomics, 14, pp.1~15 (2017)
- Don Armstrong, "Extracellular Vesicles and the Promise of Continuous Liquid Biopsies", Journal of Pathology and Translational Medicine, 52(1), pp.1~8 (2018), 대한병리학회[DOI]
- Song DH, "Myoferlin expression in non-small cell lung cancer : prognostic role and correlation with VEGFR-2expression", Oncol Lett, 11, pp.998~1006 (2016)
- Song DH, "Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma", Oncotarget, 8, pp.89033~89039 (2017)
- Choi DK, "Clinicopathological roles of S100A8and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro", Arch Dermatol Res, 306, pp.489~496 (2014)
- Arai K, "S100A8and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast", Curr Cancer Drug Targets, 8, pp.243~252 (2008)
- Su YJ, "Up-regulation of the expression of S100A8 and S100A9 in lung adenocarcinoma and its correlation with inflammation and other clinical features", Chin Med J (Engl), 123, pp.2215~2220 (2010)
- Arai K, "Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma : S100A9 expression is associated with tumor differentiation", Oncol Rep, 8, pp.591~596 (2001)
- Huang H, "Clinical significance of calciumbinding protein S100A8 and S100A9 expression in non-small cell lung cancer", Thorac Cancer, 9, pp.800~804 (2018)
- Zhang X, "Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis", Int J Cancer, 137, pp.2803~2814 (2015)
- Zhu H, "Roles of galectin-7 and S100A9 in cervical squamous carcinoma : clinicopathological and in vitro evidence", Int J Cancer, 132, pp.1051~1059 (2013)
- Roesch Ely M, "Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma", Eur J Cell Biol, 84, pp.431~444 (2005)
- Kong JP, "Loss of myeloid-related proteins 8and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation", World J Gastroenterol, 10, pp.1093~1097 (2004)
- Funk S, "High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma", Int J Cancer, 136, pp.2037~2046 (2015)
- Voss A, "Expression of S100A8", A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation, 2011, pp.585, 440~446
- El-Rifai W, "Gastric cancers overexpress S100A calcium-binding proteins", Cancer Res, 62, pp.6823~6826 (2002)
- Seth A, "Gene expression profiling of ductal carcinomas in situ and invasive breast tumors", Anticancer Res, 23, pp.2043~2051 (2003)
- Stulík J, "The analysis of S100A9and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma : the S100A9 and S100A8positive cells underlie and invade tumor mass", Electrophoresis, 20, pp.1047~1054 (1999)
- Shen J, "Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by twodimensional gel electrophoresis and mass spectrometry", Cancer Res, 64, pp.9018~9026 (2004)
- Hermani A, "Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer", Clin Cancer Res, 11, pp.5146~5152 (2005)
- Arai K, "S100A9expression in invasive ductal carcinoma of the breast : S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation", Eur J Cancer, 40, pp.1179~1187 (2004)
- Ito Y, "S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma", Pathol Res Pract, 201, pp.551~556 (2005)
- DeNardo DG, "Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity", Cancer Metastasis Rev, 29, pp.309~316 (2010)
- Gabrilovich DI, "Coordinated regulation of myeloid cells by tumours", Nat Rev Immunol, 12, pp.253~268 (2012)
